CN114081924A - Fermentation product for regulating qi and blood and preparation method and application thereof - Google Patents

Fermentation product for regulating qi and blood and preparation method and application thereof Download PDF

Info

Publication number
CN114081924A
CN114081924A CN202111386850.6A CN202111386850A CN114081924A CN 114081924 A CN114081924 A CN 114081924A CN 202111386850 A CN202111386850 A CN 202111386850A CN 114081924 A CN114081924 A CN 114081924A
Authority
CN
China
Prior art keywords
parts
blood
fermentation
regulating
raw materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111386850.6A
Other languages
Chinese (zh)
Inventor
严超
赵星
李水玲
王建云
范会芬
马若琰
王岩
赵林森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei Yiran Biotechnology Co ltd
Original Assignee
Hebei Yiran Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei Yiran Biotechnology Co ltd filed Critical Hebei Yiran Biotechnology Co ltd
Priority to CN202111386850.6A priority Critical patent/CN114081924A/en
Publication of CN114081924A publication Critical patent/CN114081924A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969Polygonatum (Solomon's seal)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/77Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/113Acidophilus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/175Rhamnosus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the technical field of medicinal and edible products, in particular to a fermentation product for regulating qi and blood and a preparation method and application thereof. The fermentation product is prepared by fermenting raw materials after enzymolysis, and the raw materials comprise: rhizoma Polygonati, Ginseng radix Rubri, fructus Jujubae, fructus Lycii and arillus longan. The fermented product has qi and blood regulating effect, and has effects of caring skin by regulating qi and blood. Through the verification of people, the fermented product can obviously improve chloasma, sallow complexion, vigorous grease secretion and other skin problems in a short time, effectively improve the sleep quality and mental state and also improve other various symptoms caused by deficiency of qi and blood.

Description

Fermentation product for regulating qi and blood and preparation method and application thereof
Technical Field
The invention relates to the technical field of medicinal and edible products, in particular to a fermentation product for regulating qi and blood and a preparation method and application thereof.
Background
The theory of traditional Chinese medicine considers that qi and blood are two basic substances in human body and are also the substance basis of normal physiological activities, and the occurrence of diseases is closely related to qi-blood disorder. Deficiency of qi and blood, i.e., deficiency of both qi and blood in traditional Chinese medicine, can cause a series of sub-health reactions, i.e., "unhappy" in traditional Chinese medicine, mild people are listened, poor in resistance, insomnia, rough skin, pale complexion, irregular menstruation, soreness and weakness of waist and knees, etc., and severe people can affect the functions of viscera, thereby causing diseases. The records of the Yuan Dynasty medical book Danxi Xin Fa: "there are many internal and must go outside", and the internal reaction of the human body must be expressed outside. In the theory of traditional Chinese medicine, facial skin is regarded as a mirror reflecting the functions of the five internal organs, and if the functions of the five internal organs are normal, qi, blood and body fluid can be delivered to the facial skin through meridians and collaterals, so that people look bright. However, if the five internal organs are deficient in qi and blood or dysfunctional, the reaction on the skin surface may be dull skin color or rough and dry skin. Therefore, people with healthy body often have good complexion, and traditional Chinese medicine beauty treatment usually focuses on internal regulation and external maintenance, and achieves the aims of beautifying, maintaining beauty and treating root causes by regulating qi and blood and nourishing internal organs.
However, it usually takes a long time to improve the external skin state by regulating qi and blood internally, and especially when safer medicine-food homologous traditional Chinese medicines are adopted, because of mild medicine property, the improvement on sleep state, mental state and poor skin state caused by deficiency of qi and blood needs a longer time, especially the improvement on the skin state needs a longer time, and the time is usually long, and the change can be obvious for several months, so that the user is hard to insist on, the trust degree of the user is reduced along with the lapse of time, and the market popularization of the medicine-food homologous products is extremely unfavorable.
Disclosure of Invention
Aiming at the technical problems in the prior art, the invention provides a fermentation product for regulating qi and blood and a preparation method and application thereof. The fermented product is used for carrying out enzymolysis and fermentation on medicinal and edible raw materials such as rhizoma polygonati, and the like, and the obtained fermented product not only has the effect of regulating qi and blood, but also has quick response, can be used for improving skin problems such as chloasma and dark skin color in a short time, and has the effects of improving sleep quality and improving mental state and energy.
In order to solve the technical problems, in a first aspect, the embodiments of the present invention provide a fermentation product for regulating qi and blood, wherein the fermentation product is prepared by performing enzymolysis on raw materials and then fermenting, and the raw materials include, by weight: 30-60 parts of rhizoma polygonati, 10-20 parts of red ginseng, 10-30 parts of Chinese date, 20-50 parts of medlar and 10-30 parts of longan.
Rhizoma Polygonati is sweet in flavor and neutral in nature, and has effects of invigorating qi, nourishing yin, invigorating spleen, moistening lung, and invigorating kidney. Modern researches show that rhizoma polygonati contains active ingredients such as rhizoma polygonati polysaccharide, saponin, flavone, alkaloid and the like, and has the effects of resisting oxidation, resisting inflammation, regulating blood sugar and blood fat, improving immunity, inhibiting tumors and the like.
Red Ginseng is warm in nature, sweet and slightly bitter in taste. It enters spleen, lung, heart and kidney meridians. Has effects of invigorating qi and nourishing blood.
The Chinese dates are sweet in taste and warm in nature, enter spleen and stomach channels, and have the effects of tonifying middle-jiao and Qi, tonifying spleen and stomach, nourishing blood and soothing nerves, promoting production of body fluid, regulating yingfen and weifen and removing vexation.
The medlar is sweet in taste and neutral in nature, enters liver and kidney meridians, and has the effects of tonifying liver and kidney, replenishing vital essence and improving eyesight. The medlar contains polysaccharide, fatty acid, betaine, carotene, riboflavin, nicotinic acid, amino acid, vitamin C, various trace elements and the like, and has the functions of enhancing the immunologic function, delaying senility, resisting tumors, reducing blood fat, protecting the liver, promoting hematopoiesis and the like.
Longan has sweet taste, mild nature and warm property, and has the effects of invigorating heart and spleen, replenishing qi and blood, invigorating spleen and stomach, and nourishing muscle. Arillus longan contains protein, fat, saccharide, organic acid, crude fiber, vitamins and minerals, and has effects of inhibiting lipid peroxidation and improving antioxidase activity, and has certain antiaging effect.
The raw materials in the fermented product are matched with each other, so that the effects of strengthening body resistance, eliminating pathogenic factors, promoting blood circulation, removing blood stasis, regulating metabolism function and promoting blood circulation can be achieved, the effect of regulating qi and blood can be achieved, and the effects of maintaining beauty and keeping young can be achieved through qi and blood regulation. In vitro experiments and animal experiments prove that the fermentation product has stronger antioxidant capacity and tyrosinase activity inhibiting capacity, can inhibit the secretion of proinflammatory factors IL-6, TNF-alpha and IL-1 beta, promotes the secretion of anti-inflammatory factors IL-10, and can prolong the natural life of fruit flies. Through the verification of people, the fermented product can obviously improve the skin problems of chloasma, sallow complexion, vigorous grease secretion and the like in a short time, effectively improve the sleep quality and the mental state, and can also improve the symptoms of irregular menstruation, dysmenorrheal, red blood silk of eyes and the like caused by deficiency of qi and blood.
According to the first aspect, the rhizoma polygonati, red ginseng, Chinese date, medlar and longan are selected according to the following weight parts: 40-50 parts of rhizoma polygonati, 13-17 parts of red ginseng, 15-25 parts of Chinese date, 30-40 parts of medlar and 15-25 parts of longan.
Preferably, the sealwort, the red ginseng, the Chinese date, the medlar and the longan are prepared according to the following weight parts: 45 parts of rhizoma polygonati, 15 parts of red ginseng, 20 parts of Chinese date, 35 parts of Chinese wolfberry and 20 parts of longan.
In combination with the first aspect, the enzyme for enzymolysis of the raw material may be cellulase and hemicellulase, or cellulase and alpha-amylase, wherein the dosage of the cellulase may be 0.8-1.2% and the dosage of the hemicellulase or alpha-amylase may be 0.3-0.5% on a dry matter basis. The enzymes can fully decompose the cell walls of the raw materials in the enzymolysis process, improve the release amount of effective components and improve the functions of the fermentation product in the aspects of improving sleep, spirit and skin states.
With reference to the first aspect, the fermentation bacteria for fermenting the raw material comprise lactobacillus plantarum Lp45, and may further comprise at least one of lactobacillus rhamnosus LR519 and lactobacillus acidophilus La28, and more preferably lactobacillus plantarum Lp45 and lactobacillus rhamnosus LR519 are combined in a mixing ratio of 1: 1-1: 2. The zymophyte can decompose macromolecular substances in the traditional Chinese medicine raw materials into micromolecular substances which are beneficial to the absorption and utilization of organisms in the fermentation process, the bioavailability and the onset speed of the fermentation product are improved, the effects of improving sleep, spirit and skin states can be achieved under the conditions of low dosage and short taking time, and the effect is better when the lactobacillus plantarum Lp45 and the lactobacillus rhamnosus LR519 are combined for use.
Wherein, the lactobacillus plantarum Lp45 is disclosed in the patent with the application number CN201310587738.8 (a lactobacillus plantarum and application thereof), and the preservation number is CGMCC NO. 8072; lactobacillus rhamnosus LR519 has been disclosed in patent with application number CN201910129081.8 (application of Lactobacillus rhamnosus and its compound bacteria powder in product for preventing and treating vaginitis), with collection number CGMCC No. 15969; lactobacillus acidophilus is disclosed in the patent with the application number of La28CN201610381849.7 (a Lactobacillus acidophilus La28 with immunoregulation and anti-allergic functions and its application), and the preservation number is CGMCC No. 11506.
With reference to the first aspect, the polygonatum sibiricum is polygonatum sibiricum. By using rhizoma polygonati as a raw material, the obtained fermentation liquor has stronger in-vitro oxidation resistance.
In a second aspect, an embodiment of the present invention further provides a preparation method of the qi and blood regulating fermented product, specifically including the following operations:
mixing the raw materials with water, pulping, performing enzymolysis, fermenting, and performing solid-liquid separation to obtain a liquid phase.
With reference to the second aspect, the preparation method may further include steaming the polygonatum sibiricum for 50-80 min before mixing and pulping the raw materials with water. Experiments show that the stimulating taste can be generated after the direct fermentation of the sealwort, and the fermentation after steaming can obviously reduce the stimulating feeling and increase the content of soluble sugar in sealwort fermentation products, thereby improving the sweetness of the product. The steamed polygonatum sibiricum is soaked in water for 6-8 hours according to the ratio of 1:8, so that the polygonatum sibiricum can be softened in hard cores, pulping can be smoothly carried out, cell wall breaking in the enzymolysis process can be promoted, and effective components can be fully released.
With reference to the second aspect, the temperature of the enzymolysis is 40 to 50 ℃, the time of the enzymolysis is 90 to 120min, and the more preferable time of the enzymolysis is 90 to 120 min.
With reference to the second aspect, the fermentation time can be selected from 50 to 60 hours; the fermentation temperature can be 37 +/-1 ℃.
Drawings
FIG. 1 is a comparison of the in vitro antioxidant capacity of example 1 and comparative examples 1 and 2 in effect example 1 of the present invention;
FIG. 2 is a comparison result of in vitro antioxidant capacity of examples 1, 7, 8, 9 and comparative examples 5 to 8 in effect example 1 of the present invention;
FIG. 3 shows the results of comparison of polysaccharide contents of rhizoma Polygonati in examples 1 and 6 and comparative examples 3 and 4 in example 3 of the effect of the present invention;
FIG. 4 is a result of comparing tyrosinase activity inhibition rates of example 1 and comparative example 8 in effect example 4 of the present invention;
FIG. 5 is a comparison result of in vitro anti-inflammatory test of example 1 and comparative example 8 in effect example 5 of the present invention;
FIG. 6 is a graph showing the life span of naturally aging female Drosophila melanogaster in each group in example 6 of the effect of the present invention;
FIG. 7 is a graph showing the life span of naturally aging male Drosophila melanogaster in each group in example 6 of the effect of the present invention;
FIG. 8 is a graph showing the skin condition improving effect of the fermented product obtained in example 1 in example 7 of the present invention;
FIG. 9 shows the effect of improving sleep in the fermented product obtained in example 1 in example 7 of the present invention;
FIG. 10 is a graph showing the effect of improving mental state of the fermented product obtained in example 1 in example 7 of the effect of the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Rhizoma Polygonati, also called JITOSHEN, has effects of invigorating spleen, moistening lung, promoting fluid production, quenching thirst, and is sweet in taste, mild in nature, and easily accepted by weak people, and is suitable for people with spleen and stomach deficiency cold, asthenia, listlessness, lung dryness, dry cough, diabetes, etc. Modern researches show that rhizoma polygonati contains active ingredients such as rhizoma polygonati polysaccharide, saponin, flavone, alkaloid and the like, and has the effects of resisting oxidation, resisting inflammation, regulating blood sugar and blood fat, improving immunity, inhibiting tumors and the like. The invention takes the sealwort as the main fermentation substrate, and combines the red ginseng, the Chinese date, the medlar and the longan which have the effects of invigorating qi, activating blood, nourishing yin and tonifying kidney, and can strengthen body resistance to eliminate pathogenic factors, activate blood circulation, dissipate blood stasis, regulate the metabolism function of a human body, improve the blood circulation of the human body, thereby achieving the effects of regulating qi and blood and beautifying.
The active ingredients of the traditional Chinese medicine are complex, and the extract obtained by any extraction method can produce expected effects. According to the invention, while the raw materials are screened, the extraction method of effective components is also investigated by combining different raw material combinations, the raw materials with homology of medicine and food are finally determined to be matched for use, the raw materials containing rhizoma polygonati, red ginseng, Chinese date, medlar and longan are subjected to extraction of the effective components in a mode of enzymolysis and fermentation, and the fermented product is prepared.
The fermented product is proved to have the capacity of inhibiting melanin synthesis key enzyme-tyrosinase and the effects of inflammation inhibition and aging resistance through in vitro cell experiments and fruit of drosophila, and the use effect of the crowd verifies that the fermented product can effectively improve the skin state, the sleep state and the mental state.
The following examples are intended to illustrate the invention in more detail.
In the following examples, Polygonatum sibiricum, Red Ginseng, Zizyphi fructus, Lycii Frutus and Euphoria longana were obtained from Hongmon, Anguo, Chinese medicine science and technology, Inc.
Examples 1 to 5
Embodiments 1 to 5 of the present invention provide qi and blood regulating fermented products, and the raw materials in each embodiment are shown in table 1:
table 1 examples 1 to 5 raw material ratios
Example 1 Example 2 Example 3 Example 4 Example 5
Rhizome of Chinese Thalictrifoliate Polygonatum 45 40 50 30 60
Red ginseng 15 17 13 20 10
Chinese date 20 15 25 10 30
Chinese wolfberry 35 30 40 20 50
Longan fruit 20 25 15 30 10
The preparation method of the above examples 1 to 5 is:
weighing the raw materials according to the weight part ratio, steaming the polygonatum sibiricum for 30-90 min by using steam, then soaking the polygonatum sibiricum for 8 hours by using 8 times of water, adding other raw materials, and pulping together;
adding enzyme, carrying out enzymolysis at 40-50 ℃ for 90-120 minutes, heating to 115 ℃ for 20min to inactivate enzyme, adding zymophyte, fermenting at 37 +/-1 ℃ for 50-60 h, filtering to remove residues, filling the obtained filtrate, and sterilizing at 90-95 ℃ for 30min to obtain the product.
Specific production parameters of examples 1 to 5 are shown in Table 2.
TABLE 2 examples 1-5 preparation Process parameters
Figure BDA0003367352210000061
Examples 6 to 9
The raw material ratios of examples 6 to 9 were the same as those of example 1, and the enzyme or fermentation tubes were different from those of example 1. The preparation process parameters of examples 6 to 9 are shown in Table 3.
Table 3 example 6 preparation process parameters
Figure BDA0003367352210000071
Comparative example
The following comparative examples are fermentation products obtained by carrying out enzymolysis with other enzymes and fermentation with other fermentation strains using other species of polygonatum as a raw material in addition to example 1.
The sealwort types of the comparative examples 1 and 2 are different from the example 1, and the rest raw materials and the preparation process parameters are the same as the example 1. The enzymes used in the enzymatic hydrolysis in comparative examples 3 and 4 are different from those in example 1, and the raw materials and the preparation process parameters are the same as those in example 1, as shown in table 4.
TABLE 4 comparative examples 1 to 4
Figure BDA0003367352210000072
The fermentation bacteria used in the comparative examples 5 to 7 are different from those in example 1, and the raw materials and the preparation process parameters are the same as those in example 1. Comparative example 8 was not fermented and the starting materials and other preparation process parameters were the same as in example 1, as shown in table 5.
TABLE 5 comparative examples 5 to 8
Figure BDA0003367352210000081
Effect example 1
The effect examples show the in vitro antioxidant ability of the fermentation products obtained in examples 1, 7, 8 and 9, comparative examples 1 and 2 (different species of polygonatum sibiricum) and comparative examples 5 to 7 (different fermentation tubes).
1. Determination of DPPH radical scavenging Capacity
By adopting the DPPH free radical scavenging capability kit G0128W, DPPH free radicals have single electron, strong absorption is generated at 517nm, and the alcoholic solution is purple. When the free radical scavenger exists, the absorption of the free radical scavenger disappears gradually due to the single electron pairing with the free radical scavenger, and the lighter the color is, namely the lower the A value is, so that the DPPH scavenging capacity in the sample is quantitatively analyzed.
DPPH radical clearance (%) (1- (a)Measurement of-AControl of)÷ABlank space)×100]%
2. Measurement of OH.scavenging ability
OH. kit G0125W was used to generate OH. with Fenton reaction system, the reaction was as follows:
Fe2++H2O2→Fe3++OH·+OH
hydroxyl radicals generated by Fenton reaction react with salicylic acid, and products have special absorption at 510 nm. And (3) judging the capability of the test object for removing the hydroxyl radicals by adopting a fixed reaction time method according to the absorbance value of the test object at 510 nm.
Removal rate (%) for OH ═ for control tube a510Assay tube A510) Control tube A510×100%
3. ABTS free radical scavenging ability
The ABTS free radical scavenging kit G0127W is adopted, ABTS is a mediator substance, and K2S2O8 and ABTS are used for directly generating stable cationic free radical ABTS +, and an antioxidant substance reacts with ABTS + to enable a reaction system to fade. Since the maximum absorption wavelength of ABTS +. radical ions is 734nm, the concentration of ABTS +. radical ions can be detected by A734 nm.
Samples were processed according to the instructions and absorbance was measured using a microplate reader. The above kits were purchased from tsuzhou grizzi biotechnology limited.
The test results are shown in fig. 1 and 2.
As can be seen from FIG. 1, in example 1, compared with comparative examples 1 and 2, the Oh & clearing rate, DPPH clearing rate and ABTS clearing rate of Polygonatum cyrtonema Hua are all significantly higher than those of Polygonatum cyrtonema Hua and Curcuma rhizome essence. Meanwhile, according to the taste evaluation results, the fermented products obtained in the examples 1-5 (all adopting polygonatum odoratum) are proper in sweetness and sourness, full in taste, free of bad flavor and optimal in score. By combining the antioxidant capacity and the taste evaluation results, the polygonatum kingianum is the better choice for the fermentation product of the invention.
As can be seen from FIG. 2, compared with comparative examples 5 to 8, the fermented products obtained in examples 1, 7, 8 and 9 have obviously higher antioxidant capacity than that of unfermented comparative example 8 and that of comparative examples 5 to 7 without Lactobacillus plantarum Lp45, and the fermented product fermented by the combination of Lactobacillus plantarum Lp45 and Lactobacillus rhamnosus LR519 has the strongest antioxidant capacity.
Effect example 2
The fermented products obtained in examples 1 to 9 and comparative examples 5 to 7 were evaluated for taste. 10 panelists were healthy and tasted normally, and were not smoking, drinking, or spicy and pungent foods for 12 hours before the evaluation, and the fermented products of examples and comparative examples were scored according to the sensory evaluation criteria of table 6, and the scoring results of each example are shown in table 7.
TABLE 6 sensory evaluation criteria and scores
Figure BDA0003367352210000091
Figure BDA0003367352210000101
TABLE 7 scoring results of fermented products obtained in examples and comparative examples
Taste scoring Sourness and sweetness scores Evaluation of mouthfeel Total score of
Example 1 29 29 The sour feeling is soft, the medicinal materials have sweet taste and are sour and sweet 58
Example 2 29 27 The sour feeling is soft, the medicinal materials have sweet taste, and the sour and sweet are more harmonious 56
Example 3 28 28 The sour feeling is soft, the medicinal materials have sweet taste, and the sour and sweet are more harmonious 56
Example 4 25 26 Weak sour taste and obvious sweet taste 51
Example 5 25 27 Weak sour taste and obvious sweet taste 52
Example 6 22 25 Weak sour taste and obvious sweet taste 47
Example 7 18 20 The sour taste is weak, but no obvious sweet taste of the medicinal materials exists 38
Example 8 21 24 Weak sour taste and obvious sweet taste 45
Example 9 23 26 Weak sour taste and obvious sweet taste 49
Comparative example 5 12 11 Strong sour sensation and sour irritation in the mouth 23
Comparative example 6 9 11 Disharmony of sour feeling in the back 20
Comparative example 7 10 12 The sour feeling is not obvious, and the fermentation flavor is not prominent 22
The results show that the fermented product provided by the embodiment of the invention has good mouthfeel, and is superior to the fermented products of the embodiments, wherein the fermented product fermented by combining lactobacillus plantarum Lp45 and lactobacillus rhamnosus LR519 has optimal mouthfeel, proper sour and sweet taste, and no obvious stimulation and sour taste.
Effect example 3
In the effect example, the fermentation products prepared in examples 1 and 6 and comparative examples 3 and 4 were subjected to crude sugar content measurement, and on the basis of the same raw materials and preparation process parameters, different enzymolysis times were respectively adopted in the enzymolysis process, and the obtained fermentation products were subjected to crude sugar content measurement.
Glucose standard solution preparation: accurately weighing 10mg of anhydrous glucose dried to constant weight, placing in a 100ml volumetric flask, adding distilled water to dissolve and dilute to scale, and shaking uniformly.
Sample preparation: 15ml of each of the fermentation products obtained in examples 1 and 6 and comparative examples 3 and 4 was precisely aspirated, absolute ethanol was added to each of the fermentation products to make the alcohol content reach 80% v/v, the mixture was thoroughly stirred and mixed, and then centrifuged at 4000r/min for 5min, the supernatant was discarded, and the residue was washed with 80% v/v ethanol for 3 times. Dissolving the residue with water, and diluting to 250ml to obtain test solution.
Preparation of a standard curve: respectively and precisely sucking 0.1mg/ml glucose standard solution 0, 0.1, 0.2, 0.4, 0.6, 0.8 and 1.0ml and supplementing water to 2 ml. Then adding 1ml of 5% phenol test solution respectively, shaking up, adding 5.0ml of concentrated sulfuric acid quickly, shaking up, heating in boiling water bath for 1min, taking out, quickly cooling in ice water to room temperature, taking phenol-concentrated sulfuric acid solution as a blank, measuring absorbance at the position of 485nm to obtain a regression equation Y which is 5.5025X +0.1428, and r which is 0.9995.
And (3) sample content determination: preparing a sample solution according to a preparation method of a test sample solution, precisely absorbing 1.0ml of the sample solution into a test tube with a plug, respectively adding 1.0ml of a 5% phenol solution, shaking up, rapidly adding 5.0ml of concentrated sulfuric acid, shaking up, heating in a boiling water bath for 15min, taking out, rapidly cooling in ice water to room temperature, measuring absorbance at a wavelength of 485nm by taking a blank solution of a test machine as a reference, and substituting into a regression equation to calculate the content of crude polysaccharide in the sample.
The results are shown in fig. 3, the content of the polysaccharides from polygonatum sibiricum is used as an evaluation index, the content of the polysaccharides from huangjing in the products obtained in example 1 (cellulase and hemicellulase) and example 6 (cellulase and alpha-amylase) is significantly higher than that in comparative example 3 and comparative example 4, the content of the polysaccharides from huangjing in the products obtained in example 1 is slightly higher than that in example 6, the content of the polysaccharides from huangjing in the products obtained in example 1 is significantly higher than that in the products obtained in example 6 when the products are subjected to enzymolysis at 50 ℃ for 90min, and the content of the polysaccharides from huangjing in the products is not significantly different from that in the products obtained in example 120 min.
Effect example 4
The tyrosinase activity inhibition test was performed on the products obtained in example 1 and comparative example 8.
Tyrosinase is a key enzyme in skin melanin biosynthesis, and oxidizes L-tyrosine into L-dopa, which is then oxidized into quinone, which spontaneously undergoes a series of reactions to form melanin. Therefore, the activity of tyrosinase is inhibited, and the synthesis of melanin can be effectively inhibited.
(1) Reagent: tyrosinase, activity is more than or equal to 1000unit/mg solid; levodopa with purity not less than 98%; tyrosinase solution: prepared by 100 mu g/mL of disodium hydrogen phosphate-citric acid buffer solution with the pH of 6.8 for temporary use; levodopa solution: prepared by a pH6.8 disodium hydrogen phosphate-citric acid buffer solution with the concentration of 1mg/mL, and stored in a dark place; positive control: kojic acid with purity not less than 98.5%.
(2) The experimental method comprises the following steps: the positive control was diluted to 1mg/mL, 0.2mg/mL, 0.04mg/mL, 0.008mg/mL series concentration gradients with pH6.8 disodium phosphate-citric acid buffer to verify the assay system. Treating a test object: the test substance is diluted into a multi-concentration sample by using a disodium hydrogen phosphate-citric acid buffer solution. Referring to Table 8, use 1A 0mL test tube is provided with a sample tube (T) and a sample background (T)0) Enzyme reaction tube (C) and solvent background (C)0) For each sample, 3 parallel tubes are required to be set for each sample tube (T) of each concentration to be tested, and 3 parallel tubes are required to be set for the enzyme reaction tube (C). In the sample tube (T) and sample background (T)0) 1mL of the same concentration of each of the sample solutions, an enzyme reaction tube (C) and a solvent background (C)0) 1mL of disodium hydrogen phosphate-citric acid buffer was added. Adding 0.5mL of tyrosinase solution into each of the sample tube (T) and the enzyme reaction tube (C), and obtaining a sample background (T)0) With background of solvent (C)0) The samples were mixed well with tyrosinase in 0.5mL disodium hydrogen phosphate-citric acid buffer and incubated in a 37 ℃ water bath for 10 min. And sequentially adding 2mL of levodopa solution into each tube, controlling the reaction time of each tube to be 5 minutes, immediately transferring each tube of reaction solution into a cuvette, and measuring the light absorption value at 475 nm.
TABLE 8 sample addition requirements
T-sample tube T0Background of sample C-enzyme reaction tube C0Background of solvent
Sample solution/ml 1 1
PBS solution/ml 0.5 1 1.5
Tyrosinase solution/ml 0.5 0.5
Levodopa solution/ml 2 2 2 2
(3) And (4) calculating a result: tyrosinase inhibition [% 1- (T-T)0)/(C-C0)]X 100%, T-sample tube light absorption value, namely the light absorption value of the solution after the sample reacts with tyrosinase; t is a unit of0-sample background absorbance; c, averaging the light absorption values of the enzyme reaction tube for 3 times, namely the light absorption value of the reaction of tyrosinase and dopa when no sample is added; c0-background absorbance of solvent.
(4) And (3) test validity verification: each batch of experiment requires the test of adding a positive control, IC of kojic acid50The test system was considered to be effective when the concentration of the sample to be tested (corresponding to the 50% inhibitory effect) was 0.05 mg/mL-0.15 mg/mL.
The tyrosinase activity inhibition rates of the products obtained in the example 1 and the comparative example 8 and the Lp45+ LR519 mixed fermentation liquor are shown in FIG. 4, and it can be seen that the tyrosinase activity inhibition rate of the fermentation liquor obtained by fermenting the raw material of the application with Lactobacillus plantarum Lp45 and LR519 is remarkably higher than that of the fermentation liquor of the comparative example 8 and the strain fermentation liquor which are not fermented, and the tyrosinase inhibition capability of the raw material of the application after fermentation is remarkably improved.
Effect example 5
This effect example the fermentation products obtained in example 1 and comparative example 8 were subjected to in vitro anti-inflammatory tests.
(1) Cells and reagents
RAW264.7 (mouse mononuclear macrophage leukemia cells), wuhan punuosai life science ltd; DMEM high-glucose medium, Invitrogen, usa; fetal bovine serum, diabody (penicillin/streptomycin), trypan blue, shanghai bio-engineering ltd; neutral red kit, bi yun tian; LPS, Sigma, usa; IL-6, IL-10 and TNF-alpha kits, Beijing Sizhenbai Biotech limited.
(2) Cell culture
RAW264.7 cells were cultured in DMEM complete medium containing 10% fetal calf serum and 1% streptomycin double antibody at 37 deg.C and 5% CO2And culturing in an incubator with saturated humidity, and taking cells in logarithmic growth phase for experiment.
(3) Co-incubation of samples with cells
Cell plating: the concentration of RAW.264.7 cells was adjusted to 2.0X 105cfu/mL, 2mL of cell culture medium per well of a 24-well plate is inoculated, and 2mL of fresh culture medium is replaced after 16-20h of culture for adherence. And randomly setting a control group and an experimental group, adding 100 mu L of sample into the experimental group for intervention, respectively adding DMEM with the same dose into a blank control group and an inflammation model control group, and adding 2 mu L of LPS (lipopolysaccharide) into the model control group for inflammation induction (the final concentration is 1 mu g/mL). After 24h of co-incubation, collecting cell culture solution of each group, centrifuging for 10min at 1000r/min, collecting supernatant, subpackaging in a sterile centrifuge tube, and preserving at-80 ℃ for later use. The secretion of IL-6, IL-10, IL-1. beta. and TNF-. alpha.cytokines was determined according to the ELISA kit instructions.
The results are shown in FIG. 5 and Table 9.
TABLE 9 Effect on macrophage RAW264.7 secretion of inflammatory factors
Figure BDA0003367352210000131
Figure BDA0003367352210000141
As can be seen from the results, compared with the blank control, the products obtained in the comparative example 8 and the example 1 can promote the immune cells to secrete the cytokines IL-6, TNF-alpha and IL-10; compared with a model control, the products obtained in the comparative example 8 and the example 1 can promote the cells to produce less proinflammatory factors IL-6 and TNF-alpha and promote the secretion of the inflammation inhibiting factor IL-10; compared with the comparative example 8, the product obtained in the example 1 after fermentation can stimulate macrophages to produce less proinflammatory factors IL-6, TNF-alpha and IL-1 beta, and can promote the secretion of the inflammation inhibiting factor IL-10.
Effect example 6
Effect example the fermented products obtained in examples and comparative examples were subjected to Drosophila anti-aging test
The wild type fruit fly Canton-S is provided by the national academy of sciences SIBCB fruit fly resource and technical platform. Collecting the eclosion copulated fruit flies within 8h, separating male and female, and culturing in an incubator at the culture temperature (25 +/-1) DEG C and the relative humidity of 50% -60%.
(1) Media preparation
Basic culture medium: 81.5g of cane sugar, 9.2g of yeast powder, 1.3g of sodium benzoate, 108.5g of corn flour, 8.2g of agar and 1000ml of pure water;
negative control group (comparative example 8 group): 81.5g of sucrose, 9.2g of yeast powder, 1.3g of sodium benzoate, 108.5g of corn flour, 8.2g of agar and 1000ml of water extract;
example 1 fermentation broth low dose group: 81.5g of cane sugar, 9.2g of yeast powder, 1.3g of sodium benzoate, 108.5g of corn flour, 8.2g of agar, 500ml of fermentation liquor and 500ml of pure water;
example 1 fermentation broth high dose group: 81.5g of sucrose, 9.2g of yeast powder, 1.3g of sodium benzoate, 108.5g of corn flour, 8.2g of agar and 1000ml of fermentation liquor;
(2) grouping fruit flies
Taking 5-day-old male and female fruit flies, and randomly dividing the fruit flies into the 4 groups respectively, wherein each group of male and female flies is provided with 10 pipes and 20 pipes.
(3) Experiment of Drosophila life
The life test of the fruit flies mainly inspects three indexes: and (4) drawing a life-span curve of the fruit flies according to the average life span of the fruit flies, the half death time of the fruit flies and the maximum life span of the fruit flies. The number of fruit fly deaths was recorded every 2d, and the medium was changed 1 time every 4d until all the flies had died.
Average life: average number of total drosophila deaths per group;
half the death time: half the number of days of drosophila death in each group;
maximum life: average number of surviving days of the last dead 20 flies in each group.
Statistical analysis is carried out on the survival rates of the drosophila melanogaster of the blank group, the comparison example 8 group, the fermentation liquor low-dose group in the example 1 and the fermentation liquor high-dose group in the example 1, the results are shown in fig. 6 and fig. 7, the survival curves of the sample group and the blank control group in the male and female drosophila melanogaster can be obviously separated, the curve is integrally higher than that of the comparison example 8 group, namely, the natural life of the drosophila melanogaster can be prolonged by the fermentation liquor with the high and low doses in the example 1 (p is less than 0.05).
The statistical results of the life span of each group of drosophila are shown in table 10.
TABLE 10 Natural aging Life of the groups of Drosophila melanogaster
Figure BDA0003367352210000151
As can be seen from the results, the high-dose fermentation liquid of example 1 improves the average life span of female drosophila by 12.4%, the maximum life span by 4% and the half death time by 21.3%; the average life of the male drosophila is improved by 12.27 percent, the maximum life is improved by 20.01 percent, and the half death time is improved by 28.46 percent. Compared with the blank group, the comparative example 8 group can not improve the natural life of female drosophila melanogaster, but can improve the maximum life of male drosophila melanogaster by 7.9 percent and the average life by 4.08 percent.
Effect example 7
This effect example was performed by performing population verification on the fermentation product obtained in example 1.
(1) Screening the group of people: screening people who have skin problems such as acne, chloasma and dark skin, poor sleep, poor mental state and the like caused by deficiency of qi and blood;
(2) trial period and feedback: the sample specification is 30 mL/bottle; the product can be drunk after opening the cover, 1 bottle after breakfast and supper, and the administration period is 1 month
Data acquisition: and filling questionnaires before and after trial, performing survey revisit on trial personnel, and counting the improvement conditions of various symptoms and the improvement rate of people. The results are shown in fig. 8 to 10 and table 11.
TABLE 11 trial rate of symptom improvement for the population
Number of people 32 persons
Rate of improvement of skin problems 75%
Rate of improvement of sleep quality 81.25%
Improvement of energy state 75%
The result shows that the fermented product obtained by the embodiment of the invention has obvious improvement effect on skin problems caused by deficiency of qi and blood, such as chloasma, sallow complexion, vigorous oil secretion and other symptoms, and the overall effective rate reaches 75%; the effective rate of improving sleep quality reaches 81.25 percent, and the effective rate of improving energy and mental state reaches 75 percent; besides, test-taking personnel feed back the normal menstruation, the relief of dysmenorrheal and the disappearance of red blood filaments of eyes after test-taking, which are symptoms caused by deficiency of qi and blood, so that the fermented oral liquid is proved to have obvious effect on regulating deficiency of qi and blood.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents or improvements made within the spirit and principle of the present invention should be included in the scope of the present invention.

Claims (10)

1. The fermentation product for regulating qi and blood is characterized by being prepared by fermenting raw materials after enzymolysis, wherein the raw materials comprise the following components in parts by weight: 30-60 parts of rhizoma polygonati, 10-20 parts of red ginseng, 10-30 parts of Chinese date, 20-50 parts of medlar and 10-30 parts of longan.
2. The qi and blood regulating fermented product according to claim 1, wherein the sealwort, red ginseng, Chinese date, medlar and longan are prepared from the following components in parts by weight: 40-50 parts of rhizoma polygonati, 13-17 parts of red ginseng, 15-25 parts of Chinese date, 30-40 parts of medlar and 15-25 parts of longan.
3. The qi and blood regulating fermented product according to claim 2, wherein the sealwort, red ginseng, Chinese date, medlar and longan are prepared in parts by weight as follows: 45 parts of rhizoma polygonati, 15 parts of red ginseng, 20 parts of Chinese date, 35 parts of Chinese wolfberry and 20 parts of longan.
4. The qi and blood regulating fermentation product according to any one of claims 1 to 3, wherein the enzymes for enzymolysis of the raw materials are cellulase and hemicellulase, or cellulase and alpha-amylase.
5. The qi and blood regulating fermented product according to any one of claims 1 to 3, wherein the fermentation bacteria used for fermenting the raw material comprise Lactobacillus plantarum Lp45, and the preservation number of the Lactobacillus plantarum Lp45 is CGMCC NO. 8072.
6. The fermentation product for regulating qi and blood of claim 5, wherein the fermentation tubes for fermenting the raw material further comprise at least one of Lactobacillus rhamnosus LR519 and Lactobacillus acidophilus La28, wherein the Lactobacillus rhamnosus LR519 has a collection number of CGMCC No.15969, and the Lactobacillus acidophilus La28 has a collection number of CGMCC No. 11506.
7. The qi and blood regulating fermented product according to claim 5, wherein the fermenting bacteria used for fermenting the raw material are Lactobacillus plantarum Lp45 and Lactobacillus rhamnosus LR 519.
8. The qi and blood regulating fermented product according to any one of claims 1 to 3, wherein the rhizoma Polygonati is Polygonatum Canaliculatum.
9. The method for producing a qi and blood regulating fermented product according to any one of claims 1 to 8, comprising the steps of:
mixing the raw materials with water, pulping, performing enzymolysis, fermenting, performing solid-liquid separation, and collecting liquid phase.
10. The method for preparing a qi and blood regulating fermented product according to claim 9, further comprising steaming rhizoma Polygonati for 50-80 min before mixing the raw materials with water and pulping.
CN202111386850.6A 2021-11-22 2021-11-22 Fermentation product for regulating qi and blood and preparation method and application thereof Pending CN114081924A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111386850.6A CN114081924A (en) 2021-11-22 2021-11-22 Fermentation product for regulating qi and blood and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111386850.6A CN114081924A (en) 2021-11-22 2021-11-22 Fermentation product for regulating qi and blood and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN114081924A true CN114081924A (en) 2022-02-25

Family

ID=80302748

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111386850.6A Pending CN114081924A (en) 2021-11-22 2021-11-22 Fermentation product for regulating qi and blood and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN114081924A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103642716A (en) * 2013-11-21 2014-03-19 河北一然生物科技有限公司 Lactobacillus plantarum and application thereof
CN106011006A (en) * 2016-06-01 2016-10-12 河北然生物科技有限公司 Lactobacillus acidophilus La28 with immunoregulation function and allergy-resisting function and applications of lactobacillus acidophilus La28
CN107496375A (en) * 2017-07-31 2017-12-22 陕西医药控股医药研究院有限公司 A kind of preparation method of herbal mixture granule
CN109700008A (en) * 2018-12-29 2019-05-03 中国科学院天津工业生物技术研究所 Chinese medicine tradition five-color health preserving fermented food and preparation method thereof
CN110016442A (en) * 2019-02-21 2019-07-16 河北一然生物科技有限公司 The application of Lactobacillus rhamnosus and its composite bacterium powder in prevention and treatment vaginitis product
CN110973633A (en) * 2019-12-30 2020-04-10 成都医学院 Ginseng essence chewable tablet and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103642716A (en) * 2013-11-21 2014-03-19 河北一然生物科技有限公司 Lactobacillus plantarum and application thereof
CN106011006A (en) * 2016-06-01 2016-10-12 河北然生物科技有限公司 Lactobacillus acidophilus La28 with immunoregulation function and allergy-resisting function and applications of lactobacillus acidophilus La28
CN107496375A (en) * 2017-07-31 2017-12-22 陕西医药控股医药研究院有限公司 A kind of preparation method of herbal mixture granule
CN109700008A (en) * 2018-12-29 2019-05-03 中国科学院天津工业生物技术研究所 Chinese medicine tradition five-color health preserving fermented food and preparation method thereof
CN110016442A (en) * 2019-02-21 2019-07-16 河北一然生物科技有限公司 The application of Lactobacillus rhamnosus and its composite bacterium powder in prevention and treatment vaginitis product
CN110973633A (en) * 2019-12-30 2020-04-10 成都医学院 Ginseng essence chewable tablet and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
百科知识大全: "黄精桂圆枸杞红枣养生茶,补气血滋润养颜丰胸", 《HTTP://WWW.BK55.CN/9186.HTML》 *
翟桂荣等: "《翟桂荣每日指导•坐月子饮食护理+新生儿养育》", 30 November 2016, 中国轻工业出版社 *

Similar Documents

Publication Publication Date Title
CN102669772B (en) Traditional Chinese medicine stomach-benefiting health-care beverage
AU2020100782A4 (en) Red food comprising composite small molecule peptides and use thereof in repairing oxidative damage of organism
CN103689563A (en) Health-preserving health food formula beneficial for improving sleep and preparation method thereof
CN103387899B (en) Black tea wine and production method thereof
CN102960411A (en) Cake and manufacturing method thereof
CN111903964A (en) Traditional Chinese medicine fermented health food beneficial to sleep and preparation method thereof
CN112314819A (en) Plant beverage for improving sleep and preparation method thereof
CN103462022A (en) Cordyceps militaris nourishing paste and preparation method thereof
CN110710678A (en) Marine polypeptide donkey-hide gelatin paste capable of nourishing liver and kidney, nourishing blood and soothing nerves and preparation method thereof
CN108813501A (en) With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung
CN106924548A (en) The medicine and preparation method of a kind of fatigue-relieving
CN110810693A (en) A beverage composition containing Ampelopsis grossedentata and its preparation method
CN111264877A (en) Preparation method of medicinal and edible high-fiber functional food
CN106520493A (en) Loquat fruit wine and preparation method thereof
CN102925313A (en) Brewing method of nourishing longan wineBrewing method of nourishing longan wine
CN110093239A (en) A kind of beautiful assembled alcoholic drinks of promise and preparation method thereof
CN114081924A (en) Fermentation product for regulating qi and blood and preparation method and application thereof
CN107372947B (en) Tea bag type blood sugar reducing tea and preparation method thereof
CN112076292A (en) Powder with functions of enhancing immunity and regulating kidney yin deficiency and preparation method thereof
CN105410915A (en) Black garlic and soybean peptide oral liquid and preparation method thereof
CN111184157A (en) Health-care apple vinegar beverage for preventing diabetes and preparation method thereof
CN106668332B (en) Passion fruit buccal tablet and preparation method thereof
CN110623266A (en) Health food for assisting in reducing blood sugar and preparation method thereof
KR20210081649A (en) Manufacturing method of beverage composition for improving asthma, bronchitis or pneumonia comprising fermented extract of Aster tataricus as effective component
CN109876053A (en) A kind of acne-removing inflammation-diminishing, removing toxic substances of clearing liver prescription and its preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20220225